Short answer. Because names travel more easily than plants. And the "indica", "sativa" or "hybrid" tag beside the name is no better: it's one species, nearly everything sold is a hybrid, and the tag doesn't predict chemistry or effects (see indica, sativa and ruderalis). Studies sampling retail cannabis found genetic outliers within most same-named strains [2], genome-wide similarity between "indica" and "sativa" labelled samples [3], and labels that only loosely track chemistry [4]. Some names are consistent; many are not. Trust sources and evidence, not names.
What the studies found
| Study |
What they did |
Key finding |
Evidence |
| Sawler et al. 2015 [1] |
14,031 SNPs in 81 marijuana and 43 hemp samples |
Genetic structure only moderately correlated with reported sativa/indica ancestry; strain names often did not reflect a meaningful genetic identity |
Supported |
| Schwabe & McGlaughlin 2019 [2] |
10 microsatellites; same-named strains from dispensaries in three US states |
Most strains had at least one genetic outlier; after removing outliers many strains were fairly stable; type labels did not match genetic groups |
Supported (limited sample, 3 states) |
| Watts et al. 2021 [3] |
>100,000 SNPs and chemical profiles of hundreds of samples |
"Sativa" and "indica" labelled samples were genetically indistinct genome-wide; labels associated with a few terpenes (myrcene, guaiol, β- and γ-eudesmol for "indica"; bergamotene, farnesene for "sativa") linked to terpene synthase gene regions |
Supported |
| Smith et al. 2022 [4] |
Lab data from 89,923 samples in six US states |
Distinct chemotypes exist, but commercial labels don't consistently align with them; some strain names were consistent, others "consistently inconsistent" |
Supported |
| Jikomes & Zoorob 2018 [5] |
Washington State lab data |
Reported THC varied systematically by testing lab |
Supported |
| Henry et al. 2020 [6] |
22-SNP assay on 420 accessions from licensed producers |
Clear population structure linked to chemotype; genetic identity relates to chemical composition |
Supported |
| Zhang et al. 2021 [7] |
Hemp cultivars from different suppliers |
Same-named cultivars from different sources flowered differently |
Supported (hemp) |
Why it happens
- Seed vs clone. A name sold as seed is a population of different genotypes; a clone name is one genotype. Both get the same name.
- Renaming and borrowing. Cuts renamed to sound new; popular names reused on unrelated genetics.
- Segregation. Even honest seed lines vary, especially F1s of heterozygous clones and F2s.
- Mix-ups. Labels lost in nurseries, mother rooms and supply chains.
- Marketing labels. "Indica" and "sativa" on menus mostly track expected effect and aroma, not ancestry [3].
- Lab variation. Potency differences partly reflect the lab, not the plant [5]. Flower labelled above ~35 % total cannabinoids isn't credible; see buyer beware.
What this means for you
| You want to... |
Do this |
| Buy seed you can trust |
Prefer lines with a GenetixBay record at L2+ from a certified breeder, batch records and grower journals |
| Trust a clone |
Ask for documented chain of custody and, for important cuts, a genotype comparison with a reference sample |
| Compare two "same" strains |
Compare sources and, if needed, DNA; don't rely on name or THC number |
| Choose by effect |
Use chemistry (cannabinoids and dominant terpenes) as a rough guide; effects are reported, not promised |
How GenetixBay handles names
- A GB-GEN is "this name as released by this breeder or source". Two lines with the same name from different sources are separate records linked as
shares_name, never merged on name alone.
- Aliases and misspellings are recorded with sources.
- Every lineage claim carries an evidence level (L0-L4). See documenting lineage evidence.
Common mistakes
- "It says Blue Dream, so it's the Blue Dream." Maybe. Check the source.
- Treating "indica = sedating, sativa = energising" as genetics. It's marketing shorthand loosely tied to a few terpenes (Contested as an effect predictor) [3].
- Dismissing all names. Some are consistent, and a well-documented line is meaningful.
Evidence
- Within-name genetic inconsistency: Supported by multiple independent studies [1][2].
- Indica/sativa labels not reflecting genome-wide ancestry: Supported [1][3].
- Weak alignment between labels and chemotype: Supported [4].
- Lab effects on potency: Supported [5].